Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE 12 (2017) 3, e0173374, 1-10
- Ereignis
-
Veröffentlichung
- (wo)
-
Münster
- (wer)
-
Universitäts- und Landesbibliothek Münster
- (wann)
-
2018
- Urheber
-
Dhayat, Sameer
Mirgorod, Philip
Lenschow, Christina
Senninger, Norbert
Anthoni, Christoph
Vowinkel, Thorsten
- URN
-
urn:nbn:de:hbz:6-17109672466
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dhayat, Sameer
- Mirgorod, Philip
- Lenschow, Christina
- Senninger, Norbert
- Anthoni, Christoph
- Vowinkel, Thorsten
- Universitäts- und Landesbibliothek Münster
Entstanden
- 2018
Ähnliche Objekte (12)
Current and future biomarkers for pancreatic adenocarcinoma
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma
Eighteen Month Interval Growth of Terminal Ileal Primary Adenocarcinoma: A Consideration for Current Screening Guidelines
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Current standard and future perspectives in first- and second-line treatment of metastatic pancreatic Adenocarcinoma
Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
Current and future biomarkers for pancreatic adenocarcinoma
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma
Eighteen Month Interval Growth of Terminal Ileal Primary Adenocarcinoma: A Consideration for Current Screening Guidelines
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Current standard and future perspectives in first- and second-line treatment of metastatic pancreatic Adenocarcinoma
Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
Current and future biomarkers for pancreatic adenocarcinoma
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma
Eighteen Month Interval Growth of Terminal Ileal Primary Adenocarcinoma: A Consideration for Current Screening Guidelines
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Current standard and future perspectives in first- and second-line treatment of metastatic pancreatic Adenocarcinoma